Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boston Institute of Biotechnology provides full-spectrum CDMO services from preclinical through commercial scale-up. It has completed over 160 projects spanning all clinical phases and operates the world’s first ultra-large bioreactor with a working volume up to 30,000L. The company recently expanded its global capacity to over 200,000L for biologics manufacturing. As a service provider rather than drug developer, it does not have its own clinical results.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boston Institute of Biotechnology.